Sep 28 Watch 6:49 How and why we need to get the lead out of our lives By PBS News Hour Our love/hate relationship with lead is as old as history itself. The origin of "plumbing" comes from the Latin word for lead. But only in the 1970s did we realize the consequences of even low doses of the hazardous metal,… Continue watching
Sep 27 Watch 3:11 How caring for a dying husband made life worth living By PBS News Hour Continue watching
Sep 27 Baby born from 3 parents a victory for new, controversial procedure By Nsikan Akpan The first baby born via a technique that mixes DNA from three parents raises familiar questions about regulatory loopholes and genetics. Continue reading
Sep 25 Freeze-dried drug factories could make various medicines, just add water By Eric Boodman, STAT This device is called the Freezemobile, and it isn’t your standard household appliance. Continue reading
Sep 24 The drug industry might finally have an answer for migraines By Damian Garde, STAT There are few effective treatments for migraines -- but that could soon change. Continue reading
Sep 23 With an increase in EpiPen use among seniors, Medicare spending up 1,100 percent By Julie Appleby and Mary Agnes Carey, Kaiser Health News The total number of Medicare beneficiaries using EpiPens climbed 164 percent while Medicare spending skyrocketed nearly 1,100 percent from 2007 to 2014, a new report shows. Continue reading
Sep 23 20 million would lose health coverage under Trump plan, study says By Ricardo Alonso-Zaldivar, Associated Press A new study that examines some major health care proposals from the presidential candidates finds that Donald Trump would cause about 20 million to lose coverage while Hillary Clinton would provide coverage for an additional 9 million people. Continue reading
Sep 22 McConnell releases stopgap spending bill, anti-Zika funds By Andrew Taylor, Associated Press The Senate's top Republican on Thursday unveiled legislation to prevent a government shutdown next weekend and provide more than $1 billion to battle the Zika virus. Continue reading
Sep 21 Mylan CEO defends EpiPen cost to angry lawmakers By Mary Clare Jalonick, Associated Press The head of pharmaceutical company Mylan is defending the cost for life-saving EpiPens, signaling the company has no plans to lower prices despite a public outcry and questions from skeptical lawmakers. Continue reading